Next Generation News and Research

RSS

New genetic analysis system for forensic DNA testing laboratories launched

Life Technologies Corporation today announced the launch of a new genetic analysis system designed to optimize data quality and deliver increased reliability, performance, quality assurance and ease-of-use specifically for forensic DNA testing laboratories.

24 Feb 2010

BD Biosciences initiates next-generation flow cytometer

BD Biosciences, a segment of BD, announced today the launch of the BD FACSAria™ III Cell Sorting System, a next-generation flow cytometer with the ability to run complex multicolor experiments using up to six lasers.

From BD (Becton, Dickinson and Company) 23 Feb 2010

UCI researchers create new breed of flightless mosquitoes for dengue control

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing - or even eliminating - dengue transmission. Males of the strain can fly but do not bite or convey disease.

23 Feb 2010

ResMed launches S9 sleep apnoea therapy platform in Europe

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes.

From ResMed Corp 22 Feb 2010

Caliper Life Sciences forms SAB to develop additional solutions for next generation sequencing workflows

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.

22 Feb 2010

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

For nearly half a century, scientists have been trying to figure out how to build a cost-effective and reasonably sized X-ray laser that could, among other things, provide super high-resolution imaging. And for the past two decades, University of Colorado at Boulder physics professors Margaret Murnane and Henry Kapteyn have been inching closer to that goal.

22 Feb 2010

Nanotechnology could aid the future of development of Arab region, says TWAS

"Nanotechnology could aid the future of development of the Arab region," says Mohamed H.A. Hassan, executive director of TWAS, the academy of sciences for the developing world, and president of the African Academy of Sciences. Hassan made his remarks at a panel session, "Re-emergence of Science, Technology and Education as Priorities in the Arab World," taking place at the AAAS's annual meeting in San Diego.

22 Feb 2010

$Caliper Life Sciences introduces automated nucleic acid fractionation instrument, LabChip XT$

Caliper Life Sciences introduces automated nucleic acid fractionation instrument, LabChip XT

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced the LabChip XT, an automated nucleic acid fractionation instrument.

19 Feb 2010

BioFlorida launches The BioFlorida Institute to create programs to improve science education

BioFlorida, the statewide trade association founded in 1997 to advance Florida’s bioscience industry, has approved a plan to launch The BioFlorida Institute, a not-for-profit foundation focused on education, professional development and industry resources. The Institute, working in partnership with BioFlorida, will create programs to improve science education and support bioscience entrepreneurs and scientists throughout the state.

19 Feb 2010

Researchers use Life Technologies’ next-generation sequencing instruments for cancer research

Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.

19 Feb 2010

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Echo Therapeutics, Inc., a company developing the needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced today that the Company has made a significant advance in the product design of its Symphony tCGM device and that it has developed its next generation electronic component package.

19 Feb 2010

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

19 Feb 2010

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

19 Feb 2010

Patterson reports consolidated sales of $820,084,000 for third-quarter of fiscal 2010

Patterson Companies, Inc. today reported consolidated sales of $820,084,000 for the third quarter of fiscal 2010 ended January 23, an increase of 1% from $811,023,000 in the year-earlier quarter. Net income of $56,049,000 or $.47 per diluted share rose 6% from $52,807,000 or $0.45 per diluted share in the third quarter of fiscal 2009.

18 Feb 2010

Charity Navigator bestows MMRF coveted 4-star rating for efforts in finding cure for multiple myeloma

The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.

18 Feb 2010

PK/PD data demonstrates clear relationship between TBR-652 plasma concentrations and antiviral activity

Pharmacokinetic/pharmacodynamic (PK/PD) data for TBR-652, which is being developed by Tobira Therapeutics for the treatment of HIV infection, show a strong relationship between drug exposure and viral suppression with this next-generation CCR5 receptor antagonist. These data were presented here today at the 17th Conference on Retroviruses and Opportunistic Infections (CROI).

18 Feb 2010

febit introduces new HybSelector instrument for next-generation resequencing solutions

febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.

18 Feb 2010

PositiveID acquires intellectual property rights and assets of Easy Check Medical Diagnostics

PositiveID Corporation announced today that it has acquired intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development. Easy Check has two primary products under development: the Easy Check breath glucose detection system and the iGlucose™ wireless communication device.

17 Feb 2010

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Talecris Biotherapeutics announced today that it has received approval from Health Canada for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more purified and concentrated version of PROLASTIN® produced using advances in manufacturing technology. A similar approval for PROLASTIN-C was granted by the U.S. Food and Drug Administration on October 17, 2009.

17 Feb 2010

ONA applauds bill to protect nurses from workplace violence

The Ohio Nurses Association applauds the introduction of House Bill 450 (HB 450) on February 11, 2010, sponsored by State Representatives Denise Driehaus (D-Columbus) and Linda S. Bolon (D-Columbiana). The bill will increase the penalty for assault when the victim is a registered nurse or a licensed practical nurse engaged in the performance of official duties whom the offender knows or has reasonable cause to believe is a registered nurse or a licensed practical nurse.

17 Feb 2010

Next Generation News and Research

New genetic analysis system for forensic DNA testing laboratories launched

BD Biosciences initiates next-generation flow cytometer

UCI researchers create new breed of flightless mosquitoes for dengue control

ResMed launches S9 sleep apnoea therapy platform in Europe

Caliper Life Sciences forms SAB to develop additional solutions for next generation sequencing workflows

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

Nanotechnology could aid the future of development of Arab region, says TWAS

Caliper Life Sciences introduces automated nucleic acid fractionation instrument, LabChip XT

BioFlorida launches The BioFlorida Institute to create programs to improve science education

Researchers use Life Technologies’ next-generation sequencing instruments for cancer research

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

RainDance Technologies enters into strategic agreement with Applied Biosystems

Patterson reports consolidated sales of $820,084,000 for third-quarter of fiscal 2010

Charity Navigator bestows MMRF coveted 4-star rating for efforts in finding cure for multiple myeloma

PK/PD data demonstrates clear relationship between TBR-652 plasma concentrations and antiviral activity

febit introduces new HybSelector instrument for next-generation resequencing solutions

PositiveID acquires intellectual property rights and assets of Easy Check Medical Diagnostics

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

ONA applauds bill to protect nurses from workplace violence

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News